Should I buy or sell Walgreens Boots Alliance stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 2 sell ratings, 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" WBA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares. View WBA analyst ratings or view top-rated stocks .

What is Walgreens Boots Alliance's stock price target for 2024?

12 Wall Street research analysts have issued twelve-month target prices for Walgreens Boots Alliance's shares. Their WBA share price targets range from $21.00 to $45.00. On average, they anticipate the company's stock price to reach $28.25 in the next year. This suggests a possible upside of 27.0% from the stock's current price. View analysts price targets for WBA or view top-rated stocks among Wall Street analysts .

How have WBA shares performed in 2024?

Walgreens Boots Alliance's stock was trading at $26.11 on January 1st, 2024. Since then, WBA stock has decreased by 14.8% and is now trading at $22.24. View the best growth stocks for 2024 here .

When is Walgreens Boots Alliance's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 26th 2024. View our WBA earnings forecast .

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) announced its quarterly earnings results on Thursday, January, 4th. The pharmacy operator reported $0.66 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.62 by $0.04. The pharmacy operator earned $36.70 billion during the quarter, compared to analysts' expectations of $34.95 billion. Walgreens Boots Alliance had a net margin of 0.40% and a trailing twelve-month return on equity of 10.48%. The firm's revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.16 EPS. Read the conference call transcript .

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance announced a quarterly dividend on Wednesday, January 3rd. Stockholders of record on Tuesday, February 20th will be paid a dividend of $0.25 per share on Tuesday, March 12th. This represents a $1.00 dividend on an annualized basis and a yield of 4.50%. The ex-dividend date is Friday, February 16th. Read our dividend analysis for WBA .

Is Walgreens Boots Alliance a good dividend stock?

Walgreens Boots Alliance (NASDAQ:WBA) pays an annual dividend of $1.92 per share and currently has a dividend yield of 8.63%. WBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 290.91%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, WBA will have a dividend payout ratio of 54.86% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for WBA .

What ETFs hold Walgreens Boots Alliance's stock?

ETFs with the largest weight of Walgreens Boots Alliance (NASDAQ:WBA) stock in their portfolio include Invesco Dow Jones Industrial Average Dividend ETF (DJD) , FT Vest DJIA Dogs 10 Target Income ETF (DOGG) , Invesco S&P Ultra Dividend Revenue ETF (RDIV) , Sound Equity Dividend Income ETF (DIVY) , Sound Equity Income ETF (SDEI) , First Trust Dow 30 Equal Weight ETF (EDOW) , USCF Dividend Income Fund (UDI) and Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) .

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?

Walgreens Boots Alliance updated its FY24 earnings guidance on Thursday, January, 4th. The company provided earnings per share guidance of $3.20-$3.50 for the period, compared to the consensus estimate of $3.32.

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com . Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T) , Intel (INTC) , CVS Health (CVS) , Johnson & Johnson (JNJ) , Walt Disney (DIS) , Cisco Systems (CSCO) , AbbVie (ABBV) , Verizon Communications (VZ) , Pfizer (PFE) and Exxon Mobil (XOM) .

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Charles Schwab Investment Management Inc. (0.76%), LSV Asset Management (0.52%), Dimensional Fund Advisors LP (0.39%), Sumitomo Mitsui Trust Holdings Inc. (0.36%), Swiss National Bank (0.27%) and Edgar Lomax Co. VA (0.24%). Insiders that own company stock include John Patrick Driscoll , Kevin M Ban , Nancy M Schlichting, Nancy M Schlichting , Richard P Gates , Rosalind G Brewer , Timothy C Wentworth , Valerie B Jarrett and Walgreens Boots Alliance, Inc. View institutional ownership trends .

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Walgreens Boots Alliance have any subsidiaries?

The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, Bond Drug Company of Illinois LLC, Boots Opticians Professional Services Limited, Boots Properties Limited, Boots Property Partnerships, Boots Retail (Ireland) Limited, Boots Retail (Thailand) Limited, Boots UK Limited, Duane Reade, Farmacias Benavides S.A.B. de C.V., Innovation Associates Inc, Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Shields Health Solutions, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Specialty Pharmacy LLC, and Waltrust Properties Inc.. Read More

Lowest-Rated StocksLowest-Rated

NASDAQ:WBA

Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

$22.24

-0.30 (-1.33%)

(As of 02/9/2024 08:57 PM ET)

Compare

Today's Range: $22.16
▼
$22.63
50-Day Range: $20.51
▼
$26.65
52-Week Range: $19.68
▼
$37.13

Volume: 8.95 million shs
Average Volume: 17.07 million shs
Market Capitalization: $19.18 billion

P/E Ratio: 33.70
Dividend Yield: 8.63%
Price Target: $28.25

Get Walgreens Boots Alliance alerts:

Walgreens Boots Alliance MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 27.0% Upside
$28.25 Price Target
Short Interest: Healthy
5.14% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -2.09
Upright™ Environmental Score
News Sentiment: 0.71
Based on 16 Articles This Week
Insider Trading: Balanced
Insiders Both Buying and Selling
Proj. Earnings Growth: 7.69%
From $3.25 to $3.50 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.67 out of 5 stars

Retail/Wholesale Sector

16th out of 209 stocks

Drug Stores & Proprietary Stores Industry

1st out of 4 stocks

3.0

Analyst's Opinion

Consensus Rating
Walgreens Boots Alliance has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 8 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $28.25, Walgreens Boots Alliance has a forecasted upside of 27.0% from its current price of $22.24.
Amount of Analyst Coverage
Walgreens Boots Alliance has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
5.14% of the float of Walgreens Boots Alliance has been sold short.
Short Interest Ratio / Days to Cover
Walgreens Boots Alliance has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Walgreens Boots Alliance has recently decreased by 2.51%, indicating that investor sentiment is improving.

2.5

Dividend Strength

Dividend Leadership
Walgreens Boots Alliance is a leading dividend payer. It pays a dividend yield of 8.63%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Walgreens Boots Alliance does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Walgreens Boots Alliance is 290.91%. Payout ratios above 75% are not desirable because they may not be sustainable.
Dividend Sustainability
Based on earnings estimates, Walgreens Boots Alliance will have a dividend payout ratio of 54.86% next year. This indicates that Walgreens Boots Alliance will be able to sustain or increase its dividend.

2.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Walgreens Boots Alliance has received a 9.05% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Physical retail of dental health products at a pharmacy", "Wholesale of pharmaceuticals", and "Physical retail of pharmaceuticals at a pharmacy" products. See details.
Environmental Sustainability
The Environmental Impact score for Walgreens Boots Alliance is -2.09.

2.1

News and Social Media Coverage

News Sentiment
Walgreens Boots Alliance has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Retail/Wholesale companies.
News Coverage This Week
MarketBeat has tracked 16 news articles for Walgreens Boots Alliance this week, compared to 16 articles on an average week.
Search Interest
Only 148 people have searched for WBA on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
MarketBeat Follows
47 people have added Walgreens Boots Alliance to their MarketBeat watchlist in the last 30 days. This is an increase of 9% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Walgreens Boots Alliance insiders have sold just slightly more of their company's stock than they have bought. Specifically, they have bought $342,193.00 in company stock and sold $350,567.00 in company stock. It is common for insiders to sell company stock at intervals simply to diversify their holdings.
Percentage Held by Insiders
17.40% of the stock of Walgreens Boots Alliance is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
57.92% of the stock of Walgreens Boots Alliance is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Walgreens Boots Alliance are expected to grow by 7.69% in the coming year, from $3.25 to $3.50 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Walgreens Boots Alliance is 33.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 115.74.
Price to Earnings Ratio vs. Sector
The P/E ratio of Walgreens Boots Alliance is 33.70, which means that it is trading at a more expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 22.39.
Price to Earnings Growth Ratio
Walgreens Boots Alliance has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Walgreens Boots Alliance has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Walgreens Boots Alliance Stock (NASDAQ:WBA)

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000 doctors, health centers, pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued.

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

WBA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

WBA Stock News Headlines

February 8, 2024 | marketbeat.com

Are these frigid Dow stocks in for a longer winter? (WBA)

These three Dow laggards have suffered double-digit percentage declines this winter, contributing to the Dow’s underperformance versus other major averages.

February 5, 2024 | marketbeat.com

Verizon, Walgreens, 3M: 3 high-yield Dow stocks to buy now? (WBA)

Dow's high-yielding trio, Verizon, Walgreens, and 3M face challenges, which are reflected in their stock-price declines.

February 12, 2024 | Edge On The Street (Ad)

An Unusual Way to Invest in Gold

Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.

January 25, 2024 | marketbeat.com

Walgreens to pay $275,000 to settle allegations in Vermont about service during pandemic

Walgreens has agreed to pay $275,000 to settle allegations about service in some of the national pharmacy chain's Vermont stores during the coronavirus pandemic

January 18, 2024 | marketbeat.com

Dogs of the Dow 2024: Cheap Dividends, But Are They Values?

January 17, 2024 | marketbeat.com

3 high yield stock ETFs that make any income portfolio better (WBA)

ETFs typically include many company stocks, eliminating single-stock risk and providing major diversification benefits. Here are three of our favorites.

January 17, 2024 | marketbeat.com

Are CVS store closures prescription for better financial health? (WBA)

CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry.

February 8, 2024 | markets.businessinsider.com

Walgreens Boots Appoints Mahajan As CFO

February 12, 2024 | Edge On The Street (Ad)

An Unusual Way to Invest in Gold

February 8, 2024 | fool.com

Why Walgreens Boots Alliance Stock Slumped 13.6% in January

February 7, 2024 | finance.yahoo.com

Walgreens Boots Alliance (WBA) Stock Falls Amid Market Uptick: What Investors Need to Know

February 7, 2024 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Walgreens Boots Alliance (WBA) and Twist Bioscience (TWST)

February 7, 2024 | cnn.com

CVS fined in Ohio for understaffing pharmacy, risking staff and patient safety

February 7, 2024 | finance.yahoo.com

Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds

February 6, 2024 | americanbankingnews.com

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives Average Rating of "Hold" from Brokerages

February 5, 2024 | msn.com

Dow drops 415 points on losses for shares of McDonald's, Walgreens Boots

February 5, 2024 | finance.yahoo.com

Walgreens Partners With Colleges of Pharmacy to Advance the Pharmacy Profession

February 3, 2024 | bizjournals.com

Walgreens closing stores in Citrus Heights, North Highlands

February 3, 2024 | markets.businessinsider.com

Roxbury Walgreens Closes Despite Widespread Pushback

February 3, 2024 | americanbankingnews.com

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Director Valerie B. Jarrett Purchases 4,456 Shares

February 2, 2024 | morningstar.com

Walgreens Boots Alliance Inc

February 1, 2024 | msn.com

Dow's 282-point rally led by gains for Merck, Walgreens Boots shares

January 31, 2024 | finance.yahoo.com

Walgreens Boots Alliance (WBA) Stock Moves -0.83%: What You Should Know

January 26, 2024 | finance.yahoo.com

Walgreens Boots Alliance 2023 ESG Report: Enabling Healthy Communities

January 25, 2024 | finance.yahoo.com

Walgreens Boots Alliance Stockholders Elect Robert L. Huffines to Board of Directors

January 25, 2024 | markets.businessinsider.com

Walgreens Boots Alliance: Sell Rating Affirmed Amid Strategic Uncertainties and Growth Concerns

January 24, 2024 | bizjournals.com

Daily Digest: Hundreds of Bay Area jobs cut; Another Walgreens to close

See More Headlines

Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 12/12 Dividend: 11/13/2023
Dividend Payable: 12/12/2023
Last Earnings: 1/04/2024
Today: 2/11/2024
Ex-Dividend for 3/12 Dividend: 2/16/2024
Dividend Payable: 3/12/2024
Next Earnings (Estimated): 3/26/2024
Fiscal Year End: 8/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Retail/Wholesale
Industry: Drug stores & proprietary stores
Sub-Industry: Drug Retail
Current Symbol: NASDAQ:WBA
CUSIP: 93142210
CIK: 1618921
Web: www.walgreensbootsalliance.com
Phone: (847) 315-3700
Fax: 847-914-2804
Employees: 331,000
Year Founded: 2014

Price Target and Rating

Average Stock Price Target: $28.25
High Stock Price Target: $45.00
Low Stock Price Target: $21.00
Potential Upside/Downside: +27.0%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 12 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.66
Trailing P/E Ratio: 33.70
Forward P/E Ratio: 6.84
P/E Growth: 1.37
Net Income: $-3,080,000,000.00
Net Margins: 0.40%
Pretax Margin: -0.36%
Return on Equity: 10.48%
Return on Assets: 3.06%

Debt

Debt-to-Equity Ratio: 0.27
Current Ratio: 0.66
Quick Ratio: 0.30

Sales & Book Value

Annual Sales: $139.08 billion
Price / Sales: 0.14
Cash Flow: $6.60 per share
Price / Cash Flow: 3.37
Book Value: $32.78 per share
Price / Book: 0.68

Miscellaneous

Outstanding Shares: 862,380,000
Free Float: 712,323,000
Market Cap: $19.18 billion
Optionable: Optionable
Beta: 0.74

Social Links

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Stefano Pessina (Age 83)
Executive Chairman of the Board
Comp: $66.73k
Mr. Manmohan Mahajan (Age 45)
Senior VP & Interim Global CFO
Comp: $1.16M
Ms. Ornella Barra (Age 71)
Chief Operating Officer of International
Comp: $1.44M
Mr. John P. Driscoll (Age 65)
Executive VP & President of U.S. Healthcare
Comp: $1.55M
Mr. Timothy C. Wentworth (Age 64)
CEO & Director
Mr. Todd D. Heckman (Age 51)
VP, Interim Global Controller & Chief Accounting Officer
Dr. Neal Joseph Sample Ph.D. (Age 49)
Executive VP & Chief Information Officer
Ms. Tiffany Ann Kanaga
Vice President of Global Investor Relations
Mr. Liyue Wu
Head of M&A - Asia
Ms. Tracey D. Brown (Age 56)
Executive VP, President of Walgreens Retail & Chief Customer Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy Walgreens Boots Alliance Stock? WBA Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Walgreens Boots Alliance was last updated on Tuesday, February 6, 2024 at 8:15 PM.

Pros

Here are some ways that investors could benefit from investing in Walgreens Boots Alliance, Inc.:

Strong presence in the healthcare, pharmacy, and retail industry, operating in multiple countries including the United States, the United Kingdom, Germany, and internationally.
Diversified business segments, including U.S. Retail Pharmacy, International, and U.S. Healthcare, providing multiple revenue streams.
Offers a wide range of health and wellness services, specialty pharmacy services, and home delivery pharmacy services, catering to the growing demand for convenient healthcare solutions.
Operates pharmacy-led health and beauty retail businesses under well-known brands like Boots, Benavides, and Ahumada, providing a strong brand presence and customer loyalty.
Recent developments and partnerships in the value-based care sector, such as VillageMD, Shields, and CareCentrix, positioning the company for growth in the evolving healthcare landscape.

Cons

Investors should be bearish about investing in Walgreens Boots Alliance, Inc. for these reasons:

Intense competition in the drug stores and proprietary stores industry, which may impact market share and profitability.
Potential regulatory challenges and changes in healthcare policies that could affect the company's operations and financial performance.
Fluctuations in prescription drug prices and reimbursement rates, which could impact the company's profitability.
Ongoing challenges in the retail industry, including changing consumer preferences and increased competition from e-commerce platforms.
Uncertainty surrounding the impact of the COVID-19 pandemic on the healthcare and retail sectors, which could affect the company's financial performance in the short term.

WBA Stock Analysis - Frequently Asked Questions

Should I buy or sell Walgreens Boots Alliance stock right now?: 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 2 sell ratings, 8 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" WBA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
View WBA analyst ratings or view top-rated stocks.
What is Walgreens Boots Alliance's stock price target for 2024?: 12 Wall Street research analysts have issued twelve-month target prices for Walgreens Boots Alliance's shares. Their WBA share price targets range from $21.00 to $45.00. On average, they anticipate the company's stock price to reach $28.25 in the next year. This suggests a possible upside of 27.0% from the stock's current price.
View analysts price targets for WBA or view top-rated stocks among Wall Street analysts.
How have WBA shares performed in 2024?: Walgreens Boots Alliance's stock was trading at $26.11 on January 1st, 2024. Since then, WBA stock has decreased by 14.8% and is now trading at $22.24.
View the best growth stocks for 2024 here.
When is Walgreens Boots Alliance's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 26th 2024.
View our WBA earnings forecast.
How were Walgreens Boots Alliance's earnings last quarter?: Walgreens Boots Alliance, Inc. (NASDAQ:WBA) announced its quarterly earnings results on Thursday, January, 4th. The pharmacy operator reported $0.66 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.62 by $0.04. The pharmacy operator earned $36.70 billion during the quarter, compared to analysts' expectations of $34.95 billion. Walgreens Boots Alliance had a net margin of 0.40% and a trailing twelve-month return on equity of 10.48%. The firm's revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.16 EPS.
Read the conference call transcript.
How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?: Walgreens Boots Alliance announced a quarterly dividend on Wednesday, January 3rd. Stockholders of record on Tuesday, February 20th will be paid a dividend of $0.25 per share on Tuesday, March 12th. This represents a $1.00 dividend on an annualized basis and a yield of 4.50%. The ex-dividend date is Friday, February 16th.
Read our dividend analysis for WBA.
Is Walgreens Boots Alliance a good dividend stock?: Walgreens Boots Alliance (NASDAQ:WBA) pays an annual dividend of $1.92 per share and currently has a dividend yield of 8.63%. WBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 290.91%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, WBA will have a dividend payout ratio of 54.86% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WBA.
What ETFs hold Walgreens Boots Alliance's stock?: ETFs with the largest weight of Walgreens Boots Alliance (NASDAQ:WBA) stock in their portfolio include Invesco Dow Jones Industrial Average Dividend ETF (DJD), FT Vest DJIA Dogs 10 Target Income ETF (DOGG), Invesco S&P Ultra Dividend Revenue ETF (RDIV), Sound Equity Dividend Income ETF (DIVY), Sound Equity Income ETF (SDEI), First Trust Dow 30 Equal Weight ETF (EDOW), USCF Dividend Income Fund (UDI) and Invesco S&P 500 High Dividend Low Volatility ETF (SPHD).

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?: Walgreens Boots Alliance updated its FY24 earnings guidance on Thursday, January, 4th. The company provided earnings per share guidance of $3.20-$3.50 for the period, compared to the consensus estimate of $3.32.
What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?: 4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Walgreens Boots Alliance own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).
Who are Walgreens Boots Alliance's major shareholders?: Walgreens Boots Alliance's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Charles Schwab Investment Management Inc. (0.76%), LSV Asset Management (0.52%), Dimensional Fund Advisors LP (0.39%), Sumitomo Mitsui Trust Holdings Inc. (0.36%), Swiss National Bank (0.27%) and Edgar Lomax Co. VA (0.24%). Insiders that own company stock include John Patrick Driscoll, Kevin M Ban, Nancy M Schlichting, Nancy M Schlichting, Richard P Gates, Rosalind G Brewer, Timothy C Wentworth, Valerie B Jarrett and Walgreens Boots Alliance, Inc.
View institutional ownership trends.
How do I buy shares of Walgreens Boots Alliance?: Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Walgreens Boots Alliance have any subsidiaries?: The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, Bond Drug Company of Illinois LLC, Boots Opticians Professional Services Limited, Boots Properties Limited, Boots Property Partnerships, Boots Retail (Ireland) Limited, Boots Retail (Thailand) Limited, Boots UK Limited, Duane Reade, Farmacias Benavides S.A.B. de C.V., Innovation Associates Inc, Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Shields Health Solutions, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Specialty Pharmacy LLC, and Waltrust Properties Inc..
Read More

This page (NASDAQ:WBA) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial